Expression levels of estrogen receptor (ER) gene and three ER-related genes in metastatic ER-positive breast cancer compared with response to endocrine therapy.

被引：0

作者：

Lai, S ^{[1
]}

Valero, V ^{[1
]}

Booster, D ^{[1
]}

Fiterman, DJ ^{[1
]}

Pusztai, L ^{[1
]}

Symmans, WF ^{[1
]}

机构：

[1] UT MD Anderson Canc Ctr, Houston, TX USA

来源：

BREAST CANCER RESEARCH AND TREATMENT | 2005年 / 94卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：S60 / S60

页数：1

共 50 条

[21] Quantitative Expression of Estrogen Receptor on Relapse Biopsy for ER-positive Breast Cancer: Prognostic Impact
Dieci, Maria Vittoria
Piacentini, Federico
Dominici, Massimo
Omarini, Claudia
Goubar, Aicha
Ficarra, Guido
Conte, Pierfranco
Guarneri, Valentina
ANTICANCER RESEARCH, 2014, 34 (07) : 3657 - 3662
[22] Estrogen-induced interaction between KLF5 and estrogen receptor (ER) suppresses the function of ER in ER-positive breast cancer cells
Guo, Peng
Dong, Xue-Yuan
Zhao, Ke-Wen
Sun, Xiaodong
Li, Qunna
Dong, Jin-Tang
INTERNATIONAL JOURNAL OF CANCER, 2010, 126 (01) : 81 - 89
[23] Estrogen receptor inhibition mediates radiosensitization of ER-positive breast cancer models
Anna R. Michmerhuizen
Lynn M. Lerner
Andrea M. Pesch
Connor Ward
Rachel Schwartz
Kari Wilder-Romans
Meilan Liu
Charles Nino
Kassidy Jungles
Ruth Azaria
Alexa Jelley
Nicole Zambrana Garcia
Alexis Harold
Amanda Zhang
Bryan Wharram
Daniel F. Hayes
James M. Rae
Lori J. Pierce
Corey W. Speers
npj Breast Cancer, 8
[24] Differences in the Transcriptional Response to Fulvestrant and Estrogen Deprivation in ER-Positive Breast Cancer
Patani, Neill
Dunbier, Anita K.
Anderson, Helen
Ghazoui, Zara
Ribas, Ricardo
Anderson, Elizabeth
Gao, Qiong
A'hern, Roger
Mackay, Alan
Lindemann, Justin
Wellings, Robert
Walker, Jill
Kuter, Irene
Martin, Lesley-Ann
Dowsett, Mitch
CLINICAL CANCER RESEARCH, 2014, 20 (15) : 3962 - 3973
[25] What is the best therapy for ER-positive breast cancer?
不详
EJC SUPPLEMENTS, 2004, 2 (09): : 62 - 64
[26] Endocrine therapy resistance can be associated with high estrogen receptor α (ERα) expression and reduced ERα phosphorylation in breast cancer models
Kuske, Barbara
Naughton, Catherine
Moore, Kate
MacLeod, Kenneth G.
Miller, William R.
Clarke, Robert
Langdon, Simon P.
Cameron, David A.
ENDOCRINE-RELATED CANCER, 2006, 13 (04) : 1121 - 1133
[27] Low estrogen receptor (ER) positive breast cancer and neoadjuvant systemic therapy (NAT): Is response similar to ER plus or to ER- disease?
Landmann, Alessandra
Farrugia, Daniel J.
Diego, Emilia
Soran, Atilla
Johnson, Ronald
Bonaventura, Marguerite
Dabbs, David J.
Clark, Beth
Brufsky, Adam
Davidson, Nancy E.
Lembersky, Barry C.
Jankowitz, Rachel Catherine
Puhalla, Shannon
Ahrendt, Gretchen M.
McAuliffe, Priscilla F.
Bhargava, Rohit
JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
[28] Low phosphorylation of estrogen receptor a (ERα) serine 118 and high phosphorylation of ERα serine 167 improve survival in ER-positive breast cancer
Yamashita, Hiroko
Nishio, Mariko
Toyama, Tatsuya
Sugiura, Hiroshi
Kondo, Naoto
Kobayashi, Shunzo
Fujii, Yoshitaka
Iwase, Hirotaka
ENDOCRINE-RELATED CANCER, 2008, 15 (03) : 755 - 763
[29] Expression of estrogen receptor (ER) βcx protein in ERα-positive breast cancer:: Specific correlation with progesterone receptor
Saji, S
Omoto, Y
Shimizu, C
Warner, M
Hayashi, Y
Horiguchi, S
Watanabe, T
Hayashi, S
Gustafsson, JÅ
Toi, M
CANCER RESEARCH, 2002, 62 (17) : 4849 - 4853
[30] Estrogen Receptor Gene Polymorphism as a Possible Genetic Risk Factor for Treatment Response in ER-Positive Breast Cancer Patients
Nasr M. A. Allahloubi
Abdel-Rahman N. Zekri
Mohamed Ragab
Marwa Mohanad
Ola S. Ahmed
Salem Eid
Mohamed Ghareeb
Iman Gouda
Abeer A. Bahnassy
Biochemical Genetics, 2022, 60 : 1963 - 1985

← 1 2 3 4 5 →